Breaking News, Promotions & Moves

CARsgen Therapeutics Appoints President of U.S. Ops

Richard Daly brings 30 years of pharmaceutical industry experience, including leadership positions in multi-national corporations and biotech companies.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

p.p1 {margin: 0.0px 0.0px 8.0px 0.0px; font: 11.0px ‘Trebuchet MS’} span.s1 {letter-spacing: 0.0px} CARsgen Therapeutics Holdings Ltd., a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, has appointed Richard John Daly as President of CARsgen Therapeutics Corp., a subsidiary of the Company in the United States. Mr. Daly will report to Dr. Zonghai Li, Founder, Chairman of the Board, CEO, CSO of CARsgen Therapeutics...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters